Literature DB >> 8860202

Dextrorphan reduces infarct volume, vascular injury, and brain edema after ischemic brain injury.

C Du1, R Hu, C Y Hsu, D W Choi.   

Abstract

Focal cerebral ischemia confined to the cerebral cortex in the right middle cerebral artery (MCA) territory was induced by temporary ligation of the MCA and both common carotid arteries (CCAs). Reperfusion was initiated by releasing all three arterial occlusions after 90 min of ischemia. Infarct volume was morphometrically measured after triphenyltetrazolium chloride staining 24 h postischemia. Blood-brain barrier breakdown was assessed 4 h postischemia by measuring vascular permeability to fluorescein isothiocyanate-conjugated dextran (FITC-D), a macromolecule tracer. Ischemic brain edema was measured based on percent water content, 24 h postischemia. Dextrorphan (DX) 20-10 mg/kg given ip 15 min before ischemia reduced infarct volume in a dose-dependent manner with an apparent U-shaped dose-response curve; best protection was observed at 30 mg/kg. Posttreatment at 30 min, but not 60 min, was still effective. DX (30 mg/kg, given 15 min before ischemia) also reduced the postischemic increase in vascular permeability and brain edema in the right MCA cortex. Results from this study support the idea that NMDA receptor activation contributes to blood-brain barrier breakdown and brain edema after ischemic insults

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8860202     DOI: 10.1089/neu.1996.13.215

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  7 in total

1.  Hormesis pervasiveness and its potential implications for pharmaceutical research and development.

Authors:  Kenneth I Maynard
Journal:  Dose Response       Date:  2011-07-29       Impact factor: 2.658

2.  Homocysteine causes cerebrovascular leakage in mice.

Authors:  David Lominadze; Andrew M Roberts; Neetu Tyagi; Karni S Moshal; Suresh C Tyagi
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-10-28       Impact factor: 4.733

3.  Potentiation of NMDA receptor function by the serine protease thrombin.

Authors:  M B Gingrich; C E Junge; P Lyuboslavsky; S F Traynelis
Journal:  J Neurosci       Date:  2000-06-15       Impact factor: 6.167

4.  Exacerbation of damage and altered NF-kappaB activation in mice lacking tumor necrosis factor receptors after traumatic brain injury.

Authors:  P G Sullivan; A J Bruce-Keller; A G Rabchevsky; S Christakos; D K Clair; M P Mattson; S W Scheff
Journal:  J Neurosci       Date:  1999-08-01       Impact factor: 6.167

Review 5.  The science of cerebral ischemia and the quest for neuroprotection: navigating past failure to future success.

Authors:  Ryan C Turner; Sean C Dodson; Charles L Rosen; Jason D Huber
Journal:  J Neurosurg       Date:  2013-01-18       Impact factor: 5.115

6.  Neuroprotective effects of gelsolin during murine stroke.

Authors:  M Endres; K Fink; J Zhu; N E Stagliano; V Bondada; J W Geddes; T Azuma; M P Mattson; D J Kwiatkowski; M A Moskowitz
Journal:  J Clin Invest       Date:  1999-02       Impact factor: 14.808

7.  Deferoxamine treatment for intracerebral hemorrhage in aged rats: therapeutic time window and optimal duration.

Authors:  Masanobu Okauchi; Ya Hua; Richard F Keep; Lewis B Morgenstern; Timothy Schallert; Guohua Xi
Journal:  Stroke       Date:  2009-12-31       Impact factor: 7.914

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.